Airlines also often try to separate business travelers from leisure travelers, because business travelers are typically less price sensitive. One of the most well-known ways airlines read the travel purpose tea leaves is a weekend stay.
He left his graphic design career to care for her and their young son, Ty. Cauli said he quickly discovered there were few resources for caregivers. He took to social media to share his story and found a community of caregivers on, where he continues to post vulnerable videos about his family's daily struggles.
"I had to quit my job to go into poverty in order to get on Medicaid so that my wife could get some treatment," Cauli said in. "I've been in poverty for five years, credit card debt for five years. And I am stuck, I'm stuck, I'm stuck."He shares the hardest moments of his caregiving journey, he said, so people understand how difficult it is.
“I just felt like I had nothing to lose," Cauli told USA TODAY. “I wanted to show everybody, kind of, what it’s really like.”will be shared in a documentary on PBS. "Caregiving," which premieres June 24 at 9 p.m. EST, was created with executive producer and Academy Award-nominated actor Bradley Cooper and features caregivers from across the country alongside advocates and experts in the field.
Cooper said his own experience caring for his father, who had lung cancer, inspired the documentary. Caregivers, he said, "are heroic people."
“Their ability to focus and give all of themselves is something that I stand in awe of,” Cooper says in the film.Aminoglycosides, a class of antibiotics, were the first drugs found to help ribosomes read past these incorrect stop signals. But they come with a serious catch: high doses are needed to work, and those doses often cause side effects like
and hearing loss. This makes them risky for long-term use, especially in children or those already battling chronic illness.Now, an international team of scientists has discovered that another drug—mefloquine—could make aminoglycosides much more effective, even at lower doses. Originally used to fight malaria, mefloquine has now been shown to help ribosomes override faulty stop codons more efficiently.
The study, published in, was led by Dr. Albert Guskov at the